Novus Biologicals™ BAFF/BLyS/TNFSF13B Antibody Blocking Peptide

Catalog No.	Quantity
NBP176843E	0.05 mg

Catalog No. NBP176843E Supplier Novus Biologicals™ Supplier No. NBP176843PEP

Description

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A blocking peptide containing 16 amino acids near the carboxy terminus of human BAFF. Source: Synthetic (Accession #: NP_006564) The BAFF/BLyS/TNFSF13B Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

• Gene ID (Entrez): 10673
• Species: Human
• Content And Storage: Store at -20 C. Avoid freeze-thaw cycles.
• Formulation: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• For Use With (Application): This Peptide is Useful as a Blocking Peptide for NBP1-76843. For Further Blocking Peptide Related Protocol, Click Here .
• Gene Alias: ApoL related ligand TALL-1, B lymphocyte stimulator, BAFFB-cell activating factor, B-cell-activating factor, BLyS, BLYSB-lymphocyte stimulator, CD257, CD257 antigen, Dendritic cell-derived TNF-like molecule, DTL, TALL-1 delta BAFF, TALL1Delta4 BAFF, THANK, TNF and ApoL-related leukocyte expressed ligand 1, TNF- and APOL-related leukocyte expressed ligand 1, TNF homolog that activates apoptosis, TNFSF20, tumor necrosis factor (ligand) superfamily, member 13 b, tumor necrosis factor (ligand) superfamily, member 20, tumor necrosis factor ligand superfamily member 13 B, tumor necrosis factor superfamily, member 13 b, tumor necrosis factor-like protein ZTNF4, ZTNF4
• Gene Symbol: TNFSF13B
• Product Type: BAFF/BLyS/TNFSF13B
• Quantity: 0.05 mg
• Regulatory Status: RUO
• Source: Synthetic
• Termination: 16 amino acids near the carboxy terminus of human BAFF